Literature DB >> 1295353

An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea.

A Z Kapikian1, T Vesikari, T Ruuska, H P Madore, C Christy, R Dolin, J Flores, K Y Green, B L Davidson, M Gorziglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1295353     DOI： 10.1007/978-1-4615-3410-5_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.

Authors:  J E Bailly; J M McAuliffe; A P Durbin; W R Elkins; P L Collins; B R Murphy
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

Authors:  A C Schmidt; J M McAuliffe; B R Murphy; P L Collins
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.

Authors:  A C Schmidt; J M McAuliffe; A Huang; S R Surman; J E Bailly; W R Elkins; P L Collins; B R Murphy; M H Skiadopoulos
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.

Authors:  Alexander C Schmidt; Daniel R Wenzke; Josephine M McAuliffe; Marisa St Claire; William R Elkins; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 5.  Rotavirus vaccines: an overview.

Authors:  K Midthun; A Z Kapikian
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

6.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Serotype analysis of rotaviruses from different locations in Malaysia.

Authors:  N B Rasool; K Y Green; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro.

Authors:  Y Hoshino; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.